Serial 99221227
Live / Allowed — Notice of allowance issued (as of 20 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99221227
- Mark type
- Design / logo
- Filed
- 06 Jun 2025
- Published for opposition
- 25 Nov 2025
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Vaccines
Owner
- Alexion Pharmaceuticals, Inc., Boston, MA, US
- Alexion Pharmaceuticals, Inc., Boston, DE, US
Prosecution history
- 20 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2026 — POST PUBLICATION AMENDMENT REVIEWED – NO ACTION TAKEN
- 14 Jan 2026 — ASSIGNED TO PETITION STAFF
- 03 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Dec 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Dec 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Nov 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 23 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Oct 2025 — ASSIGNED TO EXAMINER
- 16 Oct 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 16 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Jun 2025 — APPLICATION FILING RECEIPT MAILED